Phathom Pharmaceuticals, Inc. PHAT Increase Decrease In Interest Payable Net
Increase Decrease In Interest Payable Net at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInterestPayableNet.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net?
- Phathom Pharmaceuticals, Inc. (PHAT) reported increase decrease in interest payable net of -$157K in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net decreased by 270.7% year-over-year, from $92K to -$157K.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net?
- Over 3 years (2021 to 2024), Phathom Pharmaceuticals, Inc.'s increase decrease in interest payable net has grown at a 50.7% compound annual growth rate (CAGR), from $165K to $565K.
- What does increase decrease in interest payable net mean?
- This reflects the net change in interest obligations that have been incurred but not yet paid in cash during the reporting period. It provides insight into the timing differences between interest expense recognition and actual cash outflows. A consistent increase may indicate rising debt service requirements or liquidity management strategies.